16-2108622-T-C
Variant summary
Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM5BP4_StrongBP6_Very_StrongBS1BS2
The NM_001009944.3(PKD1):c.6545A>G(p.Gln2182Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000877 in 1,560,074 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense has been classified as Likely pathogenic.
Frequency
Consequence
NM_001009944.3 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant polycystic kidney diseaseInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- polycystic kidney disease 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- autosomal recessive polycystic kidney diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Caroli diseaseInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PKD1 | NM_001009944.3 | c.6545A>G | p.Gln2182Arg | missense_variant | Exon 15 of 46 | ENST00000262304.9 | NP_001009944.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00455 AC: 693AN: 152202Hom.: 13 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00120 AC: 205AN: 170732 AF XY: 0.000822 show subpopulations
GnomAD4 exome AF: 0.000479 AC: 675AN: 1407754Hom.: 6 Cov.: 34 AF XY: 0.000398 AC XY: 277AN XY: 695372 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00455 AC: 693AN: 152320Hom.: 13 Cov.: 33 AF XY: 0.00427 AC XY: 318AN XY: 74484 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:2
PKD1: BS1, BS2 -
This variant is associated with the following publications: (PMID: 17574468, 22995991) -
not specified Benign:1
- -
Polycystic kidney disease, adult type Benign:1
- -
Polycystic kidney disease Benign:1
The PKD1 p.Gln2182Arg variant was identified in 2 of 164 proband chromosomes (frequency: 0.012) from individuals or families with polycystic kidney disease, and was not identified in 342 control chromosomes from healthy individuals. The variant was also identified in dbSNP (ID: rs147685291) as “NA”, in Cosmic 1x as a variant of unknown origin from a lung cell carcinoma and in ADPKD database as likely neutral. The variant was also identified in the 1000 Genomes Project in 31 of 5000 chromosomes (frequency: 0.0062); the NHLBI GO Exome Sequencing Project in 1 of 8452 European American (frequency: 0.0001) and 57 of 4274 African American alleles (frequency: 0.01). Furthermore the variant was identified in the Exome Aggregation Consortium database (August 8, 2016) in 83 (2 homozygous) of 24342 chromosomes (frequency: 0.003) in the following populations: African in 80 of 2954 chromosomes (frequency: 0.027), Latino in 3 of 798 chromosomes (frequency: 0.004), but was not seen in East Asian, European (Finnish), European (Non-Finnish) and South Asian populations. In addition we cannot be certain that data from control databases is specific to PKD1 and not from one of the six PKD1 pseudogenes. The variant was not identified in Clinvitae, ClinVar, GeneInsight COGR, MutDB, PKD1-LOVD and PKD1-LOVD 3.0 databases. The p.Gln2182 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant as Likely Benign. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at